Results 11 to 20 of about 175,041 (315)

Papillomavirus vaccines [PDF]

open access: yesFrontiers in Bioscience, 1998
The considerable morbidity and mortality associated with certain human papillomaviruses (HPV) has provided the impetus for HPV vaccine development. The design of such vaccines has evolved from an understanding of the nature of HPV infections and their consequences, together with evaluation of the efficacy of different approaches to vaccination in ...
Duggan-Keen, M   +3 more
openaire   +3 more sources

Human Papillomavirus Vaccines [PDF]

open access: yesThe Journal of Infectious Diseases, 2021
Abstract Human papillomavirus (HPV) vaccines are among the most effective vaccines available, the first to prevent infection by a mucosatropic sexually transmitted infectious agent and to do so without specific induction of mucosal immunity.
Lauri E, Markowitz, John T, Schiller
openaire   +2 more sources

E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I [PDF]

open access: yes, 2005
Papillomaviruses have evolved mechanisms that result in escape from host immune surveillance. The E5 protein is expressed early in papillomavirus infection in the deep layers of the infected epithelium.
Marchetti, Barbara   +9 more
core   +1 more source

High-Risk Human Papillomavirus Infection in Lung Cancer: Mechanisms and Perspectives

open access: yesBiology, 2022
Lung cancer is a very prevalent and heterogeneous group of malignancies, and most of them are etiologically associated with tobacco smoking. However, viral infections have been detected in lung carcinomas, with high-risk human papillomaviruses (HR-HPVs ...
Julio C. Osorio   +4 more
doaj   +1 more source

Human Papillomavirus

open access: yesMicrobiology Spectrum, 2016
ABSTRACT Individuals with inherited immunodeficiencies, autoimmune disorders, organ or bone marrow transplantation, or infection with human immunodeficiency virus (HIV) are at increased risk of infection with both low-risk and high-risk human papillomavirus (HPV) types.
Eileen M, Burd, Christina L, Dean
openaire   +2 more sources

Genome-wide analysis of high risk human papillomavirus E2 proteins in human primary keratinocytes

open access: yesGenomics Data, 2014
The E2 protein is expressed in the early stage of human papillomavirus (HPV) infection that is associated with cervical lesions. This protein plays important roles in regulation of viral replication and transcription.
Nuchsupha Sunthamala   +5 more
doaj   +1 more source

Expanded Basal Compartment and Disrupted Barrier in Vocal Fold Epithelium Infected with Mouse Papillomavirus MmuPV1

open access: yesViruses, 2022
Laryngeal infection with low-risk human papillomaviruses can cause recurrent respiratory papillomatosis (RRP), a disease with severe effects on vocal fold epithelium resulting in impaired voice function and communication. RRP research has been stymied by
Renee E. King   +4 more
doaj   +1 more source

Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. [PDF]

open access: yes, 2005
The development of effective strategies against cervical cancer in Africa requires accurate type specific data on human papillomavirus (HPV) prevalence, including determination of DNA sequences in order to maximise local vaccine efficacy.
Gelder, CM   +32 more
core   +1 more source

Genomic Characterisation of Canis Familiaris Papillomavirus Type 24, a Novel Papillomavirus Associated with Extensive Pigmented Plaque Formation in a Pug Dog

open access: yesViruses, 2022
Numerous large dark plaques developed over the ventrum, legs and head of a 9-year-old pug dog over a 4-year-period. Histology confirmed a diagnosis of viral pigmented plaque and a short section of a novel papillomavirus (PV) type was amplified using ...
John S. Munday   +4 more
doaj   +1 more source

Economic evaluation of human papillomavirus vaccination in the United Kingdom. [PDF]

open access: yes, 2008
OBJECTIVE: To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom. DESIGN: Economic evaluation. SETTING: UK. Population Schoolgirls aged 12 or older.
Choi, Yoon Hong   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy